American Society of Addiction Medicine
American Society of Addiction Medicine
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022
Wednesday 24th April 2024
Explore the impact of xylazine on public health with Dr. Marissa Tan, discussing its risks and the importance of clinician support.
14 minutes
Informative
Supportive
Compassionate
Educational
Non-judgmental
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Navigating Intimate Relationships
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
35 (View all)
Do you want to link to this podcast?
Get the buttons here!Xylazine: The Hidden Dangers in Philadelphia's Drug Scene
Episode Overview
- Xylazine is a sedative mixed with opioids, causing severe health issues.
- Healthcare providers should support and believe their patients.
- Testing for xylazine is limited but crucial for patient awareness.
- Educating both clinicians and patients about xylazine risks is essential.
- Policy changes are needed to support better addiction treatment.
We recommend health care providers really support their patients and believe them
Get ready to dive into the gritty details of addiction medicine with this episode of 'Addiction Medicine: Beyond the Abstract'. Hosted by Dr. Shawn McNeil, the episode features Dr. Marissa Tan, an epidemiology intelligence service fellow for the CDC. Dr. Tan shares her journey from Preventive Medicine residency in Baltimore to her current role, highlighting her passion for health equity and addiction medicine.
The episode focuses on the use of xylazine, a sedative often mixed with opioids like fentanyl, and its alarming impact on public health in Philadelphia. Known locally as 'Trank', xylazine has been causing severe wounds and infections among users, sometimes leading to limb amputations. Dr. Tan discusses the importance of recognising these risks and educating both clinicians and patients. She also emphasises the need for healthcare providers to support and believe their patients, despite limitations in testing for xylazine.
With practical advice for clinicians and a call for more supportive policies, this episode is a must-listen for anyone interested in the intersection of public health and addiction medicine. Don't miss out on these crucial insights – your understanding could make a difference.